Absci’s IPO reflects booming biotech market and growing PNW life sciences industry

Absci researchers at the company’s HQ in Vancouver, Wash. (Absci photo)The upcoming public offering for Vancouver, Wash.-based biotech company Absci reflects a soaring IPO market and adds to the growing prosperity of Pacific Northwest biotech companies. The company’s success also highlights the still-tenuous links between the life sciences communities in Portland, Seattle, and Vancouver B.C. Absci, which partners with other…
« Previous post: | Next post: »